According to a recently published report, Plandai Biotechnology Inc (OTCMKTS:PLPL) has announced that its flagship product Phytofare is to be used by USN as a green tea ingredient.
Road So Far
It’s not the first time when both the companies have entered into any such agreement. Earlier, they signed a deal under which USN was to use Phytofare in all the products manufactured or sold in Europe and South African region. With the help of this agreement, Plandai managed to market its product in the market and got an amazing response.
Now with the updated terms, Plandai and USN have signed a new deal, which will help the former expanding reach of its products in other markets. As part of this new agreement, USN will use Phytofare in a new line of products to be sold in New Zealand and Australian markets. Both the companies intend to figure out new opportunities in the market and check if their association is fruitful in the long run or not.
The senior management teams of both the companies are excited about this deal and hope that they will climb newer success ladders in the near future with each other’s help.
Another leading biotech company Metabolix, Inc. (NASDAQ:MBLX) has floated its newest project — Yield10 Bioscience. The prime objective of this launch is to commercialize and develop different innovative ideas in crop science field and expand their reach at national and international level.
According to a recent Food and Agricultural Organization report, the total population of this world will surpass 9 billion. It will give birth to an excessive need of food production. With the innovative projects under Yield10 Bioscience brand, Metabolix wishes to address such requirements in the long run.
Herborium Group, Inc. (OTCMKTS:HBRM) has come up with a new product named AcnEase to be used for natural treatments of health issues like acne and rosacea. The company has launched a host of websites for the promotion and marketing of this product on the international level.